Modern Sedation and Analgesia Strategies in Neurocritical Care.
Andrew BauershmidtTarik Al-BermaniSyed AliBrittany BassJessica DorilioJon RosenbergFawaz Al-MuftiPublished in: Current neurology and neuroscience reports (2023)
In addition to established agents such as propofol and midazolam, dexmedetomidine and ketamine are two sedative agents that play an increasingly central role, as they have a favorable side effect profile on cerebral hemodynamics and rapid offset can facilitate repeated neurologic exams. Recent evidence suggests that dexmedetomidine is also an effective component when managing delirium. Combined analgo-sedation with low doses of short-acting opiates is a preferred sedation strategy to facilitate neurologic exams as well as patient-ventilator synchrony. Optimal care for patients in the neurocritical care population requires an adaptation of general ICU strategies that incorporates understanding of neurophysiology and the need for close neuromonitoring. Recent data continues to improve care tailored to this population.
Keyphrases
- healthcare
- palliative care
- pain management
- mechanical ventilation
- quality improvement
- cardiac surgery
- end stage renal disease
- chronic kidney disease
- intensive care unit
- affordable care act
- ejection fraction
- newly diagnosed
- machine learning
- chronic pain
- blood brain barrier
- deep learning
- smoking cessation
- health insurance
- quantum dots